Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases
BACKGROUND: Effective systemic treatments have revolutionized the management of patients with metastatic melanoma, including those with brain metastases. The extent to which these treatments influence disease trajectories close to death is unknown. Therefore, this study aimed to gain insight into provided treatments and healthcare consumption during the last 3 months of life in patients with melanoma brain metastases. METHODS: Retrospective, single-center study, including consecutive patients with melanoma brain metastases diagnosed between June-2015 and June-2018, referred to the medical onco... Mehr ...
Verfasser: |
Eggen, Annemarie C.
Hospers, Geke A. P.
Bosma, Ingeborg
Kramer, Miranda C. A.
Reyners, Anna K. L.
Jalving, Mathilde |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2022 |
Reihe/Periodikum: |
Eggen , A C , Hospers , G A P , Bosma , I , Kramer , M C A , Reyners , A K L & Jalving , M 2022 , ' Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases ' , BMC Cancer , vol. 22 , no. 1 , 247 . https://doi.org/10.1186/s12885-022-09316-7 |
Schlagwörter: |
Adult
/ Aged
/ 80 and over
/ Antineoplastic Agents/therapeutic use
/ Brain Neoplasms/drug therapy
/ Emergency Medical Services/statistics & numerical data
/ Female
/ Hospitalization/statistics & numerical data
/ Humans
/ Male
/ Melanoma/drug therapy
/ Middle Aged
/ Mutation
/ Netherlands
/ Patient Acceptance of Health Care/statistics & numerical data
/ Proto-Oncogene Proteins B-raf/genetics
/ Retrospective Studies
/ Terminal Care/statistics & numerical data
/ Treatment Outcome |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-28779015 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://hdl.handle.net/11370/72f2feed-43ca-4bfa-aa69-c9742fae411a |